Integrated care boards (ICBs)
Since their inception, ICBs have had to navigate significant transformation. They are increasingly central to delivering joined-up services and driving system-wide reform. With mounting pressures on workforce, funding and accountability – ICBs must balance strategic oversight with local responsiveness. We believe greater uptake of off-patent medicines can help free up local budgets and resources while supporting population health goals through improved access to essential treatments.
Prevention and access
The NHS 10-year plan identifies a shift towards more community-delivered care and stronger emphasis on prevention. ICBs are central to delivering this vision and ensuring its success.
Despite clear recognition from central government and NHS England, the value of off-patent medicines is not always realised at local system level. If ICBs are to deliver on their prevention and access goals, they must be empowered to harness the full benefits of generics and biosimilars.
Medicines play a vital role in societal health. Our shared agenda with ICBs is to focus on increasing awareness and understanding of the opportunities ahead.
Latest industry news
Partnership will revive inactive licences to solve critical medicines shortages
By Jeremy Durrant